Initial Pre-screening for the CANaspire Gene Therapy Trial

This is a secure site, and all information will be stored and processed in a confidential way, in accordance with the Health Insurance Portability and Accountability Act of 1996, commonly known as HIPAA, the General Data Protection Regulation (GDPR), and the Aspa Therapeutics Privacy Policy. We will ask for your consent before sharing any personal information with the clinical trial sponsor (Aspa) and its screening partners. By clicking “Submit”, you are giving permission to store the personal data you have provided. You can withdraw your interest in this research opportunity at any time by emailing us at canaspire@treatcanavan.com

1
STEP 1
2
STEP 2
3
STEP 3

About your child

About you

By clicking the box that says "I Agree" below, you are consenting to the use of your personal information in accordance with the terms of that Privacy Policy.

Please note:

  • After submitting, a member of the Aspa team will contact you to follow-up.
  • By completing this form, you are not obligated to participate in the pre-screening or CANaspire Trial. You may opt out at any time.